NO972887L - Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel - Google Patents

Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel

Info

Publication number
NO972887L
NO972887L NO972887A NO972887A NO972887L NO 972887 L NO972887 L NO 972887L NO 972887 A NO972887 A NO 972887A NO 972887 A NO972887 A NO 972887A NO 972887 L NO972887 L NO 972887L
Authority
NO
Norway
Prior art keywords
piperidinedacetic
acid derivatives
derivatives useful
antagonist agent
fibrinogen antagonist
Prior art date
Application number
NO972887A
Other languages
English (en)
Other versions
NO972887D0 (no
Inventor
David George Allen
Colin David Eldred
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9426231.8A external-priority patent/GB9426231D0/en
Priority claimed from GBGB9503133.2A external-priority patent/GB9503133D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO972887D0 publication Critical patent/NO972887D0/no
Publication of NO972887L publication Critical patent/NO972887L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Denne oppfinnelse tilveiebringer forbindelsene med formel (1) 0) COjH og farmasøytisk akseptable derivater derav, hvori: X representerer enten CHj-CHj eller CH=CH; og Y "representerer et hydrogenatom eller en fenylmetylgruppe, hvori fenylgruppen eventuelt er substituert med ett eller flere halogenatomer. Forbindelser med formel (1) inhiberer blodplateaggregering.
NO972887A 1994-12-23 1997-06-20 Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel NO972887L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9426231.8A GB9426231D0 (en) 1994-12-23 1994-12-23 Chemical compounds
GBGB9503133.2A GB9503133D0 (en) 1995-02-17 1995-02-17 Chemical compounds
PCT/EP1995/005043 WO1996020192A1 (en) 1994-12-23 1995-12-21 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent

Publications (2)

Publication Number Publication Date
NO972887D0 NO972887D0 (no) 1997-06-20
NO972887L true NO972887L (no) 1997-08-20

Family

ID=26306268

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972887A NO972887L (no) 1994-12-23 1997-06-20 Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel

Country Status (21)

Country Link
US (1) US5861414A (no)
EP (1) EP0799223B1 (no)
JP (1) JPH10511375A (no)
CN (1) CN1175254A (no)
AP (1) AP9701010A0 (no)
AR (1) AR002260A1 (no)
AT (1) ATE181071T1 (no)
AU (1) AU704496B2 (no)
CO (1) CO4700291A1 (no)
DE (1) DE69510228T2 (no)
DK (1) DK0799223T3 (no)
ES (1) ES2132761T3 (no)
FI (1) FI972684L (no)
GR (1) GR3031027T3 (no)
IL (1) IL116480A0 (no)
NO (1) NO972887L (no)
NZ (1) NZ298400A (no)
PE (1) PE63696A1 (no)
SI (1) SI0799223T1 (no)
WO (1) WO1996020192A1 (no)
ZA (1) ZA951822B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760028A (en) * 1995-12-22 1998-06-02 The Dupont Merck Pharmaceutical Company Integrin receptor antagonists
GB9613096D0 (en) * 1996-06-21 1996-08-28 Glaxo Group Ltd Medicaments
IL129416A0 (en) 1996-10-14 2000-02-17 Bayer Ag New heterocyclylmethyl-substituted pyrazol derivatives
WO1998043962A1 (en) * 1997-03-28 1998-10-08 Du Pont Pharmaceuticals Company Heterocyclic integrin inhibitor prodrugs
US7141581B2 (en) * 1999-07-02 2006-11-28 Agouron Pharmaceuticals, Inc. Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
TWI262914B (en) 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
PE20010306A1 (es) * 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
MXPA03005432A (es) * 2000-12-22 2003-09-10 Wyeth Corp Compuestos de heterociclilindazol y -azaindazol como ligandos de 5-hidroxitriptamina-6.
US7008953B2 (en) 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
AR050253A1 (es) * 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
JP2025530213A (ja) 2022-09-09 2025-09-11 ミリックス ファーマ リミテッド Ｎｍｔ阻害剤を含む抗体薬物コンジュゲート及びその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681382A (en) * 1969-02-07 1972-08-01 Ciba Geigy Corp 3-aminoindazoles
JPH07501063A (ja) * 1991-11-14 1995-02-02 グラクソ、グループ、リミテッド フィブリノーゲン依存性血小板凝集阻害剤としてのピペリジン酢酸誘導体
US5219867A (en) * 1991-12-16 1993-06-15 Research Corporation Technologies, Inc. Platelet aggregation inhibitory agents
JPH05255308A (ja) * 1992-03-11 1993-10-05 Ajinomoto Co Inc ピペリジン誘導体
JP3194777B2 (ja) * 1992-03-13 2001-08-06 学校法人東京薬科大学 立体選択的ｄ−リボフラノシル化法
JPH06234633A (ja) * 1993-02-10 1994-08-23 Ajinomoto Co Inc アミン誘導体およびこれを含有する抗血小板剤

Also Published As

Publication number Publication date
CN1175254A (zh) 1998-03-04
AR002260A1 (es) 1998-03-11
FI972684A7 (fi) 1997-06-19
DE69510228T2 (de) 1999-11-04
FI972684A0 (fi) 1997-06-19
NO972887D0 (no) 1997-06-20
GR3031027T3 (en) 1999-12-31
AP9701010A0 (en) 1997-07-31
FI972684L (fi) 1997-06-19
ATE181071T1 (de) 1999-06-15
EP0799223A1 (en) 1997-10-08
NZ298400A (en) 1999-10-28
CO4700291A1 (es) 1998-12-29
JPH10511375A (ja) 1998-11-04
IL116480A0 (en) 1996-03-31
EP0799223B1 (en) 1999-06-09
SI0799223T1 (en) 1999-10-31
DK0799223T3 (da) 1999-12-27
DE69510228D1 (de) 1999-07-15
WO1996020192A1 (en) 1996-07-04
ZA951822B (en) 1996-09-26
ES2132761T3 (es) 1999-08-16
US5861414A (en) 1999-01-19
AU704496B2 (en) 1999-04-22
AU4387896A (en) 1996-07-19
PE63696A1 (es) 1997-01-11

Similar Documents

Publication Publication Date Title
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
ATE129714T1 (de) Heterocyclische biphosphonsäurederivate.
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
WO1993010091A3 (en) Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
ZA95639B (en) Substituted aromatic compounds
NO934536L (no) Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
NO944930L (no) Hemming av dysfunksjonell uterin blödning
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
ATE285410T1 (de) Naphthyridinderivate oder salze davon
DK0420121T3 (da) Antitumormiddel
MY125037A (en) 1,2,3,4 tetrahydroquinoline derivatives
CA2014521A1 (en) 2-Substituted N,N'-Ditrimethoxybenzoyl Piperazines, a Preparation Process of the Same and Therapeutic Compositions Containing Them
MX9206930A (es) Nuevos compuestos
NO20023041L (no) Fremgangsmåte for fremstilling av pyrazolopyridazinderivater
SE8303913L (sv) Heterocykliska foreningar
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
GB8701494D0 (en) Chemical compounds
DK0420224T3 (da) Anthihepatopatisk middel
DK23089D0 (da) Thioformamidderivater og deres anvendelse
NO944577L (no) Hemming av effekten av amyloidogene proteiner
ATE53022T1 (de) Alpha,alpha-diaryl-4-aryl-4-hydroxy-1-piperidin butanamid-n-oxide.
TW355184B (en) Substituted thiophenylsulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE60239324D1 (de) Phenyl- und pyridyl-piperidine mit tnf-wirkung
ATE189813T1 (de) Prostaglandin-i-analoga